[1]
M. A. Rahman, “Assessment of measurable residual disease after induction chemotherapy in acute lymphoblastic leukemia patients in a tertiary care hospital”, Int J Adv Med, vol. 11, no. 5, pp. 428–433, Aug. 2024.